Chugai Presents Results from Second Positive Global Phase III Clinical Study of Satralizumab

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced that the results from SAkuraStar Study were presented at the...

September 12, 2019 | Thursday | News
Hansoh Pharma, Atomwise partner for AI Drug Discovery

Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China,...

September 12, 2019 | Thursday | News
Daiichi Sankyo Advances [Fam-] Trastuzumab in Japan

 Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) has announced the submission of a New Drug Application...

September 10, 2019 | Tuesday | News
Invicro Appoints Hidenori Seshimo as Vice President of Biomarker Services, Japan

Invicro , a member of the Konica Minolta Group and a leading provider of biomarkers for imaging, core lab services and s...

August 30, 2019 | Friday | News
THC Global Groups' Australalia's Facility Opened by Federal Minister for Health

THC Global Group Limited (THC Global or the Company) has announced that its Southport Facility was opened by the Federal...

August 22, 2019 | Thursday | News
FDA fast tracks AstraZeneca's FARXIGA

AstraZeneca has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the deve...

August 28, 2019 | Wednesday | News
Japan's BioWa extends partnership with Cantargia

Cantargia AB and BioWa Inc. have signed an extension of the license agreement around the BioWa proprietary POTELLIGENTTe...

August 27, 2019 | Tuesday | News
Voronoi selects CDD Vault platform to manage Drug Discovery Data

Voronoi, drug discovery and development biotech company in Korea has announced that it has, after an extensive evaluatio...

August 23, 2019 | Friday | News
Innovent to develop & commercialize a novel diabetes medicine in China

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high-quality medicine...

August 22, 2019 | Thursday | News
FDA approves new antibiotic to treat community-acquired bacterial pneumonia

The U.S. Food and Drug Administration, on 19 August 2019, approved Xenleta (lefamulin) to treat adults with community-ac...

August 20, 2019 | Tuesday | News
FDA approves novel treatment for highly drug-resistant forms of TB

Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & D...

August 19, 2019 | Monday | News
Roche gets approval for oncology drug, Rozlytrek

Genentech, a Roche’s subsidiary announced that the US Food and Drug Administration (FDA) has approved Rozlytrek&tr...

August 16, 2019 | Friday | News
Certara Introduces Version 19.6 of its D360 Scientific Informatics Platform

Certara®, the global model-informed drug development and decision support leader, on 30 July 2019, announced the lau...

August 15, 2019 | Thursday | News
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Bayer AG and BlueRock Therapeutics hasannounced an agreement under which Bayer will fully acquire BlueRock Therapeutics,...

August 14, 2019 | Wednesday | News
Sun Pharma announces regulatory filing of Tildrakizumab in Japan

Sun Pharmaceutical Industries Ltd. has announced that one of its wholly owned subsidiaries has filed an application for ...

August 1, 2019 | Thursday | News
Pfizer completes acquisition of Array Biopharma

Pfizer Inc.  announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough...

July 31, 2019 | Wednesday | News
3SBio to bring first self-developed pre-filled fusion protein injection solution

3SBio Inc., a leading biopharmaceutical company in the People's Republic of China (PRC) has announced that an applicatio...

July 30, 2019 | Tuesday | News
AstraZeneca’s roxadustat reveals positive results against anaemia

AstraZeneca has announced that data from two Phase III trials evaluating the efficacy and safety of roxadustat in China....

July 25, 2019 | Thursday | News